Evidence map›Paper›PMID 37627916›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Detection of Diabetes through Microarray Genes with Enhancement of Classifiers Performance.

Dinesh Chellappan, Harikumar Rajaguru

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dinesh ChellappanDepartment of Electrical and Electronics Engineering, KPR Institute of Engineering and Technology, Coimbatore 641 407, Tamil Nadu, India.ORCID 0000-0002-6955-7646
Harikumar RajaguruDepartment of Electronics and Communication Engineering, Bannari Amman Institute of Technology, Sathyamangalam 638 401, Tamil Nadu, India.ORCID 0000-0002-2792-0945

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes is a life-threatening, non-communicable disease. Diabetes mellitus is a prevalent chronic disease with a significant global impact. The timely detection of diabetes in patients is necessary for an effective treatment. The primary objective of this study is to propose a novel approach for identifying type II diabetes mellitus using microarray gene data. Specifically, our research focuses on the performance enhancement of methods for detecting diabetes. Four different Dimensionality Reduction techniques, Detrend Fluctuation Analysis (DFA), the Chi-square probability density function (Chi2pdf), the Firefly algorithm, and Cuckoo Search, are used to reduce high dimensional data. Metaheuristic algorithms like Particle Swarm Optimization (PSO) and Harmonic Search (HS) are used for feature selection. Seven classifiers, Non-Linear Regression (NLR), Linear Regression (LR), Logistics Regression (LoR), Gaussian Mixture Model (GMM), Bayesian Linear Discriminant Classifier (BLDC), Softmax Discriminant Classifier (SDC), and Support Vector Machine-Radial Basis Function (SVM-RBF), are utilized to classify the diabetic and non-diabetic classes. The classifiers' performances are analyzed through parameters such as accuracy, recall, precision, F1 score, error rate, Matthews Correlation Coefficient (MCC), Jaccard metric, and kappa. The SVM (RBF) classifier with the Chi2pdf Dimensionality Reduction technique with a PSO feature selection method attained a high accuracy of 91% with a Kappa of 0.7961, outperforming all of the other classifiers.

Indexed as

classifiersDimensionality Reductionmachine learningpredictiontype II diabetes mellitus

Identifiers

PMID37627916
PMCPMC10453776

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.